Provided by Tiger Trade Technology Pte. Ltd.

ODDITY Tech Ltd.

13.22
+0.71005.68%
Post-market: 13.220.00000.00%19:30 EDT
Volume:851.70K
Turnover:11.13M
Market Cap:609.77M
PE:16.73
High:13.43
Open:12.53
Low:12.29
Close:12.51
52wk High:64.23
52wk Low:9.25
Shares:46.12M
Float Shares:28.59M
Volume Ratio:1.01
T/O Rate:2.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7900
EPS(LYR):1.80
ROE:16.40%
ROA:3.99%
PB:2.04
PE(LYR):7.34

Loading ...

Press Release: Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update

Dow Jones
·
Mar 30

ODDITY Tech Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
Mar 28

Oddity Tech Faces Securities Lawsuit After Stock Drops Nearly 50% on Advertising Disruption Disclosure

TIPRANKS
·
Mar 26

Oddity Tech director Michael Farello files initial beneficial ownership statement

Reuters
·
Mar 25

Key Corporate Announcements Summary for March 24 Evening

Deep News
·
Mar 24

Belief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patients

prnewswire
·
Mar 23

Oddity Tech Director Lilach Payorski Files Initial Beneficial Ownership Statement

Reuters
·
Mar 21

Oddity Tech Ltd. director Cheresniya Ohad files initial beneficial ownership statement

Reuters
·
Mar 21

Oddity Tech Ltd. CTO Niv Price Files Initial Beneficial Ownership Statement

Reuters
·
Mar 21

Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China

prnewswire
·
Mar 19

ODDITY Tech’s Exchangeable Notes Raise Dilution Risks and May Fuel Short Selling Pressure

TIPRANKS
·
Mar 19

Oddity Tech Ltd. files initial beneficial ownership statement for Chief Product Officer Shiran Holtzman-Erel

Reuters
·
Mar 19

Oddity Tech Ltd. CFO Lindsay Drucker Mann Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Oddity Tech FY2025 net revenue rose 25.2% to USD 809.84 million

Reuters
·
Mar 18

Pomerantz files securities class action against Oddity Tech Ltd. over alleged misleading statements

Reuters
·
Mar 18

Class Action Lawsuit Targets Oddity Tech Over Alleged Securities Law Violations

Reuters
·
Mar 17

Oddity Tech hit with investor class action after shares drop 49.21%

Reuters
·
Mar 16

Oddity Tech board approves USD 200 million share buyback plan

Reuters
·
Mar 12

Oddity Tech Announces $200M Share Buyback Plan

THOMSON REUTERS
·
Mar 12

Cadrenal Therapeutics Highlights Research Supporting 12-LOX Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes

GlobeNewswire
·
Mar 12